TCR signaling is mediated by intracellular signaling molecules and nuclear transcription factors, which are tightly regulated by interaction with regulatory proteins such as Grb2 and SLAP. We reported recently that TCR stimulation induces the expression of cytokine-induced SH2 protein (CIS). The expression of CIS promotes TCR-mediated activation. We have now found speci®c interactions between CIS and activated protein kinase C (PKC) a, b and q in TCR-stimulated T cells. CIS was shown by in vitro kinase assay to associate with activated PKC. In CIS-expressing T cells isolated from CIS-transgenic mice, the amount of activated PKC associated with CIS was found to increase following TCR stimulation. By immunohistochemical analysis, CIS was also found to colocalize with PKCq at the plasma membrane of activated T cells. In addition to the interaction and intracellular co-localization of the CIS and PKC, an increase in the activation of AP-1 and NF-kB was noted in CIS-expressing T cells, after stimulation by either anti-CD3/CD28 or phorbol myristate acetate + ionomycin. These results suggest that CIS regulates PKC activation, and that this may be important for the activation of both the AP-1 and NF-kB pathways in TCR signaling.
Introduction
Stimulation of the TCR by MHC±peptide complexes initiates a set of responses required for the immune system to function properly, including cell proliferation, cytokine production and apoptosis. The engagement of TCR by antigen leads to the recruitment and activation of cytosolic protein tyrosine kinases, such as Lck, ZAP-70 and SYK, which associate with and activate phospholipase (PLC) g (1±3). When PLCg is translocated to the membrane, it cleaves phosphatidylinositol (4,5)-bisphosphate, producing diacylglycerol (DAG) and inositol (1,4,5)-triphosphate. DAG activates protein kinase C (PKC), whereas inositol (1,4,5)-triphosphate mobilizes Ca 2+ from the intracellular stores (4, 5) . Elevation of the Ca 2+ level promotes early events in T cell activation by stimulating the activity of calcineurin, a Ca 2+ /calmodulin-dependent serine/ threonine protein phosphatase (6, 7) . The activated calcineurin in turn activates NF-AT (6) . NF-AT consists of a nuclear protein (AP-1) and a cytoplasmic protein (NF-ATc). NF-ATc enters the nucleus in response to elevated Ca 2+ and binds to AP-1. This duplex, in turn, binds to the NF-AT recognition sites (8, 9) . Cyclosporin A, an immunosuppressant, antagonizes calcineurin, and blocks both activation and nuclear entry of NF-ATc (7, 10) .
DAG recognizes a cysteine-rich region of PKC and activates members of the PKC family (11, 12) . More than 10 members of the PKC family have been discovered. These have been divided into subgroups according to their primary structure and their binding of Ca 2+ or phorbol ester (11, 13) . Although both conventional PKC (cPKC), such as a, bI, bII and g, and novel PKC (nPKC), such as d, e, q and h, are activated by phorbol myristate acetate (PMA), only cPKC bind Ca 2+ . Atypical PKC (aPKC), such as z and t (l), as well as PKCm/PKD are not activated by either phorbol esters or Ca 2+ , although they do bind DAG (12, 13) . The requirement for PKC in T cell activation has been demonstrated in both studies of dominant-negative and/or constitutively active mutants of PKC (14, 15) , and in studies of T cell activation using pharmaco-logical agonists and antagonists of PKC (16) . By the use of constitutively active mutants of PKCa, e and q, it has been demonstrated, in a mouse T cell line, that PKCq preferentially induces AP-1 transcriptional activity (15) . Most of the PKC are present not only in T cells, but also other types of cell, although PKCq is expressed primarily in hematopoietic cells (17) , and during immune responses is localized to the region of contact between the TCR and the antigen-presenting cell (APC) (18) . In a study of the regulation of mitogen activating protein kinases (MAPK) by PKC it was shown that, although PKCq, a and e all activate extracellular signal-regulated kinase (ERK), PKCq speci®cally cooperates with calcineurin, generating signals which converge on Rac, leading to a strong activation of c-Jun NH 2 -terminal kinase (JNK) (19) . These studies demonstrate the importance of PKC in T cell activation, as well as their distinct biological functions.
Recently, we reported that cytokine-induced SH2 protein (CIS) is an immediate-early gene that appears following TCR stimulation (20) . CIS, a member of the suppressors of cytokine signalling (SOCS) family, has been shown to be a negative regulator of cytokine signalling by inhibiting the IL-3-and erythropoietin (EPO)-mediated signal transducer and activator of transcription (STAT) 5-signaling pathway (21±24). The members of the SOCS protein family have been identi®ed on the basis of their structural similarities, all exhibiting an N-terminal region of variable length, a highly variable amino acid sequence, a central SH2 domain and a striking region of C-terminal homology designated as the SOCS box (21,25±27). Four of the members (CIS, JAB/ SOCS1/SSI, SOCS2 and SOCS3) were found to negatively regulate cytokine signal transduction by interacting with either the phosphorylated cytoplasmic domains of the cytokine receptors (21), the activated Jak kinases (26) or the STAT proteins (22) . The forced expression of CIS in one myeloid cell line (M1) was found to partially suppress IL-3-induced proliferation (21) and to negatively modulate the activation of STAT5 (22) . Recently, the suppression of STAT5 signalling in the liver, the mammary glands and the T cells of CIS-transgenic mice has also been reported (23) . We have demonstrated that CIS can be induced by TCR stimulation in T cells (20) . Through our studies of T cell activation in CIS-transgenic mice, we have also found that CD4 T cells, which express the transgene in the T cell lineage, exhibit enhanced proliferative responses upon TCR stimulation and prolonged survival of the activated T cells. The ®nding that this enhanced response of the CISexpressing CD4 T cells is correlated with a marked increase in the activation of MAPK following TCR stimulation suggests that CIS regulates MAPK activation after TCR activation.
In the present study, efforts to discover the mechanisms by which CIS affects TCR-mediated T cell activation revealed a speci®c interaction of CIS with activated PKCa, bII and q. The co-localization of CIS and PKCq to the plasma membrane of the activated T cells was observed by immunohistochemical analysis. In addition to the association of CIS with activated PKC in the TCR-stimulated T cells, an increased activation of the transcription factors AP-1 and NF-kB was also noted.
Methods

Mice
C57bl/6 mice were purchased from the Tounbjerg Breeding Centre (Ejby, Denmark). CIS-transgenic mice were established as previously described (20) . Female mice were used at 4±10 weeks of age and were maintained on standard laboratory diet.
Transfections
CIS cDNA was subcloned into the pCEP4 expression vector under the control of the cytomegalovirus promoter. Then 10 mg of the resulting plasmid was mixed with 10 7 Jurkat T cells, and pulsed at 250 V and 950 mF in a 4-mm gap cuvette using a BioRad (Hercules, CA) Gene Pulser. Stable transfectants were selected for in the presence of 400 mg/ml hygromycin, expanded in culture and used in the subsequent immunoprecipitation experiments.
Electrophoretic mobility shift assay CD4 T cells were isolated from the spleen cells of both normal and CIS-transgenic mice by anti-CD4 coated magnetic beads (Dynabeads L3T4; Dynal, Lake Success, NY). After each separation, the ef®ciency of CD4 cell puri®cation was analysed by¯ow cytometry and was routinely found to be >95%. Puri®ed CD4 T cells were stimulated by anti-CD3 and anti-CD28 or 50 nM PMA + 50 nM ionomycin for 15 min. Nuclear proteins were then isolated as previously described (28) . Double-stranded oligonucleotides derived from the consensus sequences of NF-kB or the AP-1 binding element (Promega, Southampton, UK) were labelled with 32 P. Binding assays, using 10 mg of nuclear proteins, were performed as described previously (28) . DNA±protein complexes were separated on a 4% polyacrylamide gel.
Immunoprecipitation and immunoblot analysis
Cell lysates of stimulated CD4 T cells were prepared in 1% NP-40 lysis buffer [containing protease inhibitors (Boehringer Mannheim, Basel, Switzerland) and sodium vanadate] and immunoprecipitated with either anti-CIS (Santa Cruz Biotechnology, Santa Cruz, CA) or anti-PKCq antibodies (Santa Cruz Biotechnology). Immune complexes were resolved by 10% SDS±PAGE. The anti-CIS precipitates were sequentially immunoblotted with antibodies speci®c for CIS and PKC (a, bII and q) respectively. The anti-PKCq precipitates were likewise immunoblotted with antibodies to CIS and PKCq. The Jurkat cells transfected with myc-tagged CIS were lysed in 1% NP-40 lysis buffer and precipitated with anti-myc antibody (9E10). The precipitates were blotted with anti-myc 9E10 and anti-PKCq antibodies.
Confocal immuno¯uorescence microscopy
CD4 T cells isolated from the spleens of normal mice were stimulated with or without anti-CD3 and anti-CD28 for 6 h. After stimulation, the cells were washed, ®xed and permeabilized as described previously (29) . The ®xed cells were then incubated overnight at 4°C with 1 mg/ml of anti-PKCq and with 2 mg/ml of anti-CIS antibody in PBS containing 1% BSA. After washing, cells were incubated with phycoerythrin-conjugated donkey anti-rabbit IgG antibody (1:200 dilution; Jackson, West Grove, PA) for the detection of rabbit anti-PKCq and FITC-conjugated donkey anti-goat IgG antibody (1:250 dilution; Santa Cruz Biotechnology) for the detection of goat anti-CIS antibody. The cells were then washed, mounted on glass coverslips using a SlowFade kit (Molecular Probes, Eugene, OR) and analyzed by conventional¯uorescence microscopy or by confocal microscopy (MRC 1024S; Bio-Rad).
In vitro kinase assay
PKCq from cell lysates of anti-CD3 (5 mg/ml) and anti-CD28 (4 mg/ml) or PMA + ionomycin-stimulated CD4 T cells were puri®ed by immunoprecipitation with anti-PKCq (Santa Cruz Biotechnology), as previously described (30) . The kinase activity of PKCq was measured by a 20-min incubation of immunoprecipitated PKCq with myelin basic protein (MBP) in the presence of 10 mCi [g-32 P]ATP in kinase buffer [containing 20mM HEPES (pH 7.0), 5 mM 2-mercatoethanol, 10 mM MgCl 2 , 0.1 mg/ml BSA and 10 mM unlabeled ATP] at 37°C. The phosphorylated MBP was analysed by SDS±PAGE.
Results
Co-localization of PKCq with CIS to the plasma membrane in activated T cells
The function of PKC is associated with its membrane translocation (4). More signi®cantly, PKCq is selectively translocated to the site of contact between the T cells and the APC (18) . This selective translocation was found to correlate with a selective increase in the activity of PKCq (15, 19) . None of the other cytosolic proteins co-localized with PKCq in the cytoplasmic membrane of activated T cells (18) . To our surprise, CIS translocated to the plasma membrane after TCR stimulation, as shown by immunohistochemical analysis. The co-localization of CIS with PKCq in anti-CD3/CD28 stimulated normal T cells was examined using confocal immuno¯uores-cence microscopy. Consistent with earlier published results, PKCq was translocated to the cytoplasmic membrane of the activated T cells (Fig. 1E) . A similar membrane localization of CIS was also revealed in the activated T cells (Fig. 1D) . Upon staining of the activated T cells with both anti-PKCq and Fig. 1 . Co-localization of CIS and PKCq at the plasma membrane of activated T cells. CD4 T cells isolated from spleens of normal mice were stimulated with (D±F) or without (A±C) anti-CD3 (5 mg/ml) and anti-CD-28 (4 mg/ml) for 6 h. Cells were then double stained (C and F) with anti-CIS (green) and anti-PKCq (red) antibodies. The intracellular localization was analyzed by confocal imaging.
anti-CIS antibodies, an exclusive co-localization of PKCq and CIS to the cytoplasmic membrane was demonstrated (Fig. 1F) . In contrast, it was found that in unstimulated CD4 T cells only the cytoplasm was stained with anti-PKC antibody (Fig. 1B) and that these cells were not stained at all by anti-CIS (Fig. 1A) , as indicated by the same weak staining of unstimulated CD4 T cells in the absence of anti-CIS antiserum. The co-localization of PKCq with CIS suggests a functional association of these two molecules in activated T cells.
CIS interacts with PKCa, bII and q in T cells after stimulation with anti-CD3/CD28 antibodies Recently, we have reported that CIS is an immediate-early gene induced by TCR stimulation (20) . After TCR stimulation, the expression of CIS can strongly increase the proliferative response and survival of T cells (20) . Moreover, both CIS and PKCq translocated to the cell membrane of stimulated T cells. To elucidate any direct interaction between CIS and PKCq, we ®rst stimulated CD4 T cells isolated from the spleens of C57bl/ 6 for 6 h with or without anti-CD3 (5 mg/ml) and anti-CD-28 (4 mg/ml). The stimulated CD4 T cells were then lysed in 1% NP-40 and the cleared lysates precipitated with anti-CIS antiserum. After resolving the precipitates on SDS±PAGE, the coprecipitated proteins were sequentially blotted with antisera to CIS, PKCa, bII, z, e and q (Fig. 2a) . CIS was detected in anti-CD3/CD28-stimulated, but not in unstimulated, CD4 T cells (Fig. 2a) . These data indicate that the expression of CIS can be induced by TCR stimulation, which is consistent with our previous ®ndings (20) . In anti-CD3/CD28 stimulated CD4 T cells, a speci®c interaction of PKCa, bII and q, but not PKCz and e, with CIS was demonstrated (Fig. 2a) . To further con®rm the interaction of PKC and CIS, lysates of unstimulated and anti-CD3/CD28-stimulated CD4 T cells were precipitated with anti-PKCq. The co-precipitation of CIS was con®rmed by immunoblotting with anti-CIS antiserum. Consistent with this, anti-CIS antiserum was shown to co-precipitate PKC from anti-CD3/CD28-activated CD4 T cells (Fig. 2b) . In order to further con®rm the association of CIS and PKCq, Jurkat cells were transfected with myc-tagged CIS cDNA and the transfectants subjected to immunoprecipitation with anti-myc antibody. The blotting analysis of anti-myc and anti-PKCq showed an interaction between the transfected CIS and endogenous PKCq (Fig. 2c) . Since it has been reported that PKCq is preferentially expressed in the T cells, selectively regulates JNK and co-localizes with TCR (18), the association of CIS with PKCq suggests an important role for CIS in the regulation of T cell activation.
Association of CIS with activated PKC
The activity of CIS-associated PKC was analyzed by in vitro kinase assay to further investigate its function. CD4 T cells isolated from the spleen of both normal and transgenic mice were treated with anti-CD3/CD28 for 15 min. The cells were then lysed and anti-CIS antisera used to precipitate the cleared lysates. Co-precipitated PKC were assayed for their ability to phosphorylate MBP, a substrate for PKC. The kinase activity of CIS-associated PKC was con®rmed (Fig. 3a) . We have shown that the expression of CIS can enhance both TCR and PMA + ionomycin induced TCR signalling (20) . In order to examine the activity of CISassociated PKC, CIS-expressing CD4 T cells were isolated from the spleens of CIS-transgenic mice and stimulated for different periods of time with PMA + ionomycin. After stimulation, the cells were lysed and cleared lysates precipitated with anti-CIS antiserum. The precipitates were divided into four aliquots, one for kinase assay, and the others for immunoblotting with anti-PKCq, anti-PKCa and anti-PKCbII antibodies respectively. As shown in Fig. 3(b  and c) , the activity of CIS-associated PKC was increased following stimulation. These results suggest that the association of CIS with PKC is induced by T cell activation and that CIS preferentially associates with the activated form of PKC.
Increased activity of both the AP-1 and NF-kB transcription factors in CIS-expressing T cells
We have previously reported that CIS-expressing CD4 T cells exhibited a marked increase in the activation of MAPK following TCR stimulation (20) . MAPK regulates activation of the AP-1 transcription factor, which promotes the expression of IL-2 and leads to the generation of a proliferative response in T cells following TCR stimulation (1±3). Once initiated, the proliferative response of T cells, whether induced by TCR stimulation or exposure to mitogens, is regulated by the transcription factor NF-kB, which is not directly controlled by MAPK (1±3). In order to clarify the role of CIS±PKC association in the AP-1 and NF-kB pathways, we analysed AP-1 and NFkB from both anti-CD3/CD28 or PMA + ionomycin-activated CD4 T cells for their ability to bind oligonucleotides carrying a binding site speci®c for each transcription factor. In normal CD4 T cells, stimulation by anti-CD3/CD28 or by PMA + ionomycin induced the binding of NF-kB and AP-1 to the oligonucleotides. We expected to see a greater increase in the binding of AP-1 to its consensus nucleotides in the activated CIS-expressing T cells. However, after anti-CD3/CD28 or PMA + ionomycin stimulation, we observed that the activity of both NF-kB and AP-1 was increased in the CIS-expressing T cells, compared with normal T cells (Fig. 4a and b) . The increased activity of the NF-kB signalling cascade may be due to the increased PKC activation in the CIS-expressing T cells or may, alternatively, be directly associated with the CIS molecules.
Discussion
CIS, a member of the SOCS protein family, exhibits a negative feedback function in cytokine signalling (21,22,25±27) . Studies have shown that CIS exerts this function on IL-3-, IL-2-and EPOactivated Jak±STAT5 signalling, by blocking the interaction of STAT5 and its docking sites on the cytoplasmic domain of the receptor chain (21) . In examining gene expression in activated T cells, we found that CIS is an immediate early gene induced by TCR stimulation (20) . Contrary to its inhibitory effect on STAT5 signalling pathway, CIS was found to promote TCRinduced T cell activation and to increase the activity of the MAP kinases (20) . Investigating the mechanisms underlying the increase in T cell activation by CIS, we have now shown that, after TCR stimulation, CIS selectively associates with activated PKCa, bII and q in T cells. The interaction of CIS with PKC increased both the activity and the membrane translocation of PKC. Study of the CD4 T cells from CIS-transgenic mice showed that the association of CIS and PKC correlated with an increased activation of the AP-1 transcription factor. These results clearly demonstrate that CIS is not only a negative regulator, but also enhances activation of the AP-1 transcription factor by regulation of PKC activation in T cells.
CIS is one of the STAT5-regulated genes, as the STATdependent expression of CIS in the thymus and the discovery of two STAT5 binding sites within the CIS gene promoter indicated (24, 31, 32) . CIS has thus been proposed to serve as a feedback modulator for STAT5, since expression of CIS is induced by STAT5 and it has a negative modulating effect on STAT5 activation. The mechanism mediating the inhibitory effect of CIS on STAT5 activation appears to be the interaction of CIS with the STAT5 binding sites in the receptors of IL-3, IL-2 and EPO (21±24). The early induction of CIS expression in TCR-stimulated T cells indicates that there is an alternative pathway to STAT5 for the regulation of CIS expression (20) . The strong enhancement of the proliferative response to TCR stimulation obtained in the CIS-expressing T cells suggests that the function of CIS in T cell activation is not associated with STAT5 (20) . Rather, we have shown in the present study that there is a functional interaction between CIS and PKCa, bII and q, resulting in an up-regulation of PKC activity and increased intracellular translocation of the activated PKC. Thus, the inhibitory effect of CIS on cytokine signalling is distinct from its stimulatory effect on TCR signalling.
The involvement of PKC isozymes in T cell activation was demonstrated by the activation of PKC by DAG after TCR stimulation (12, 13) . PKC has been found to be recruited to the membrane/cytoskeletal compartments of activated T cells (18, 33) . The activation and subcellular localization of PKC are important for promoting the TCR-mediated proliferation (19, 34) . In particular, the PKC isotype q was found to be selectively translocated to the site of cell contact between the APC and the T cell (18) . This was accompanied by an increased activity of PKCq (18) . In this study, PKCq activity was enhanced in CIS-expressing T cells upon TCR stimulation. These results indicate the importance of CIS in the regulation of PKCq in activated T cells. Increased activity of JNK in CIS-expressing CD4 T cells (20) supports the recent ®ndings of the involvement of PKC in the regulation of JNK activation (19) . The association of an increased activation of PKC and NF-kB in CIS-expressing T cells suggests that CISassociated PKC are involved in the regulation of TCR-mediated NF-kB activation. Indeed, the requirement of PKCq for the activation of NF-kB in T cell activation was reported recently (35, 36) . In a study of reporter genes in cells transfected with different PKC isoforms, the TCR-mediated activation of both AP-1 and NF-kB was induced only in the PKCq transfectants (35) . Even more interesting is the report that in PKCq knockout mice, the activation of MAP kinases (JNK, ERK and p38) is not altered, but the activation of both AP-1 and NF-kB is abolished in mature T cells (36) . Intact activity of JNK in T cells of PKCq knockout mice may suggest that JNK can be regulated by other PKC isoforms than PKCq or is co-regulated by PKCq and other PKC (36) . Since it has been shown that PKCq is required for the NF-kB activation in mature T cells (36) , the strong increase of NF-kB activity in CIS-expressing CD4 T cells suggests the importance of CIS±PKCq association in the regulation of NF-kB activation in T cells.
PKCq has also been found to be functionally associated with Vav in T cells (34) . By in vitro transfection of PKCq either with or without Vav, Vav has been shown to promote the translocation of PKCq from the cytosol to the membrane as well as to the cytoskeleton (34) . The co-localization of CIS and PKCq at the plasma membrane of activated T cells suggests that TCR activation and/or co-stimulatory signals may induce CIS to become involved in the formation of the T cell synapse. CIS associates with multi-isoforms of PKC, although only PKCq has been found to localize to the point of cellular contact between APC and T cells or to be involved in the regulation of JNK activity (19, 34) . However, other PKC isoforms have also been shown to be involved in TCR signalling (16,37,38 ). An involvement of both the conventional and novel isoforms of PKC in the activation of IkB kinase after TCR stimulation has been demonstrated (39) . Notably, evidence from PKCq knockout mice suggests that recruitment of conventional PKC can compensate for the absence of PKCq, to restore at least part of the biological response of TCR signalling (36) . In the present study, three PKC isoforms (a, bII and q) were found to be associated with CIS. The exclusive membrane association of CIS indicates that the three PKC isoforms colocalize with CIS at the membrane or within cytoskeletal compartments. The increased JNK activation in CIS-expressing T cells again suggests the regulation of multi-PKC by CIS.
Individual PKC isoforms appear to have roles in distinct cellular functions. The presence of activated PKCa and bII facilitates the phosphorylation of soluble lamin B leading to a rearrangement of the cytoskeleton, which may be required for formation of the T cell synapse (40) . Thus, the association of CIS with multi-PKC may be critical for the optimal activation of T cells after TCR stimulation.
Our results, and those of previous studies concerning the role of CIS in cytokine signalling, point to CIS having important biological functions in different signalling pathways, although the speci®c function is dependent upon the particular pathway. The association of CIS with PKC and the increase in NFkB activity in CIS-transgenic T cells after TCR stimulation may suggest the function of CIS in the regulation of T cell activation to be distinct from its inhibitory effect on cytokine signalling. Immune homeostasis requires the limitation of clonal expansion of activated T cells. It was recently reported that TCRmediated feedback inhibition of T cell expansion, results from an inhibitory effect of STAT5 on IL-2 signalling (41). Therefore, the reciprocal regulation of TCR and IL-2 receptor signalling by CIS may be essential for the control of both immune responses and homeostasis. 
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